Books about Ribozymes from Amazon.com

The discovery that RNA could act as a macromolecular catalyst in the cell, signified a paradigm shift in molecular biology. Ribozymes and RNA Catalysis takes the reader through the origins of catalysis in RNA and necessarily includes significant discussion of structure and folding. The main focus of the book concerns chemical mechanism with extensive comment on how, despite the importance of RNA catalysis in the cell, its origins are still poorly understood and often controversial.

The reader is given an outline of the important role of RNA catalysis in many aspects of cell function, including RNA processing and translation. There has been a significant coming together in the field of RNA in recent years and this book offers a compelling review of the whole field to date.

Written by leading experts in their field, who in turn review the structural and mechanistic data for all known ribozymes this book is well suited for undergraduates, postgraduates and researchers in catalytic chemistry as well as those in related fields who require a unique overview of the subject.

.
Price: $150.77 [Notify me when price goes down.]

Significant DNA sequence data has been made available by several important genome projects The allocation of functions to a mere string of the four letters in the code of life plays a major if not predominant role of ongoing and future research. Guided by experts in the field, Molecular Beacons: Signalling Nucleic Acid Probes, Methods, and Protocols, provides easy-to-follow experiments, commences with an introduction to the basic principles of fluorescence, and shows a diverse set of instructive examples, from probe design to applications in clinical settings, molecular beacon technology, the identification of transgenic mice, along with the potential of realtime PCR. While originally being used for fluorogenic nucleic acid probes with a stem-loop structure, molecular beacon now refers to a whole family of fluorescence-up probes. Molecular Beacons: Signalling Nucleic Acid Probes, Methods, and Protocols summarizes all the latest findings and explores powerful techniques designed for geneticist, biotechnologists, molecular and cellular biologists, researchers and developers.

.
Price: $83.51 [Notify me when price goes down.]

Institute of Cancer Research, Oslo, Norway. Features the new methods now available for gene inactivation in vitro and in vivo. Offers step-by-step protocols and other additional techniques on the analysis of ribozyme structures. For researchers. DNLM: RNA, Catalytic--Laboratory Manuals..
Price: $79.11 [Notify me when price goes down.]

Berlex Biosciences, Richmond, CA. Provides an overview of the utility of ribozymes to selectively inhibit the expression of RNA. Halftone tables, graphs, and illustrations. Modified-outline format. DNLM: RNA, Catalytic--therapeutic use. .
Price: $103.60 [Notify me when price goes down.]

This digital document is an article from BIOTECH Patent News, published by Biotech Patent News on July 1, 2000. The length of the article is 579 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Ribozyme successfully defends European patent.(Ribozyme Pharmaceuticals, Inc.)(Brief Article)
Publication:BIOTECH Patent News (Newsletter)
Date: July 1, 2000
Publisher: Biotech Patent News
Volume: 14 Issue: 7 Page: NA

Article Type: Brief Article

Distributed by Thomson Gale.
Price: $5.95 [Notify me when price goes down.]

A comprehensive collection of essential and easily reproducible techniques currently used by leading researchers to manipulate RNA molecules and to inactivate gene expression in vivo. The methods range from theoretical design to clinical application and include the synthesis and assay of ribozymes, as well as their use both in vitro and in vivo. Each method is presented by an expert with substantial hands-on experience and in far greater detail than is to be generally found in the research literature. The book will be indispensable not only to those workers new to the field, but also to experienced researchers who want to expand their range of expertise..
Price: $116.27 [Notify me when price goes down.]

Are the combined human resources at RIBOZYME PHARMACEUTICALS, INC. productive? There is no absolute answer to this question. This report considers the extent to which the company's labor deployment indicators differ from global benchmarks. In this report we consider forecasts of differences between labor ratios and the resulting return on this human investment compared to global benchmarks; the estimation of such differences is commonly called a "gap analysis." What is the ratio of short-term and long-term assets to employee? What are typical capital-labor ratios? How different are these ratios to companies serving the same link in the value chain? What are the average sales and net profits per employee compared to global benchmarks? These and over 50 other indicators of labor productivity are considered in this report. The report does so by going beyond traditional analyses by considering companies competing in the same or similar industrial classification at a global level. The goal of this report, therefore, is to assist consultants, human resource managers, strategic planners, and corporate officers in gauging estimates of a company's human resource indicators compared to firms competing or participating in the same economic sector, at the global level. This report is not about whether a particular company or industry has performed well or poorly in the past or will do so in the future. With the globalization of markets, greater foreign competition, and the reduction of entry barriers, it becomes all the more important to benchmark a company's human resource indicators against other firms on a worldwide basis. Doing so, however, is not an obvious task. First, one needs to find firms competing in the same sector, but not necessarily competing directly with the company in local markets. These firms should not be perceived, therefore, to be direct competitors to the company in question, but simply those that have been classified by various sources (e.g. EDGAR or similar foreign filings), as competing to serve customers in the same link of the value chain, or broad industrial classification, as identified by SIC, NAICS or similar codes. Second, given the international nature of the task, one needs to control for exchange rate volatility. Finally, one needs use comparable financial standards. This report overcomes these issues and gives full human resources benchmarks vis-a-vis worldwide competitors who are present in the same narrow industrial classification. Benchmarks cover labor-asset ratios, labor-liability ratios, and labor-income ratios. Since our reports are printed on demand, the statistics reported are for the latest quarter and are the most up to date available (4 updates are produced each year). Each report provides over 100 statistics and 40 graphs to the reader. This reports is on RIBOZYME PHARMACEUTICALS, INC., BOULDER, USA..
Price: $210.00 [Notify me when price goes down.]